Perrigo (PRGO) shares fell 9% in premarket trading after the company announced a strategic review of its infant formula business. The move, part of its Three-S plan—Stabilise, Streamline, Strengthen—aims to boost efficiency and shareholder value. Perrigo said multiple options are under consideration, with no set timeline for completion.